Y Wang1, N Zhao2, Q Liu1, Y Zhang2, J Qiu1, X He1, M Zhou1, H Cui1, L Lv1, X Lin1, C Zhang1, H Zhang1, R Xu1, D Zhu1, Y Dang1, X Han1, H Zhang1, H Bai1, Y Chen1, Z Tang1, R Lin1, T Yao1, J Su1, X Xu1, X Liu1, W Wang1, B Ma1, S Liu1, W Qiu1, H Huang2, J Liang2, S Wang3, R A Ehrenkranz4, C Kim5. 1. Gansu Provincial Maternity and Child Care Hospital, Lanzhou, Gansu, China. 2. Department of Environmental Health Sciences, School of Public Health, Yale University, New Haven, CT, USA. 3. Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China. 4. Department of Pediatrics, School of Medicine, Yale University, New Haven, CT, USA. 5. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Sciences, Bethesda, MD, USA.
Abstract
BACKGROUND/ OBJECTIVES: Folic acid supplementation has been suggested to reduce the risk of preeclampsia. However, results from few epidemiologic studies have been inconclusive. We investigated the hypothesis that folic acid supplementation and dietary folate intake before conception and during pregnancy reduce the risk of preeclampsia. SUBJECTS/ METHODS: A birth cohort study was conducted in 2010-2012 at the Gansu Provincial Maternity & Child Care Hospital in Lanzhou, China. A total of 10,041 pregnant women without chronic hypertension or gestational hypertension were enrolled. RESULTS: Compared with nonusers, folic acid supplement users had a reduced risk of preeclampsia (OR=0.61, 95% CI: 0.43-0.87). A significant dose-response of duration of use was observed among women who used folic acid supplemention during pregnancy only (P-trend=0.007). The reduced risk associated with folic acid supplement was similar for mild or severe preeclampsia and for early- or late-onset preeclampsia, although the statistical significant associations were only observed for mild (OR=0.50, 95% CI: 0.30-0.81) and late-onset (OR=0.60, 95% CI: 0.42-0.86) preeclampsia. The reduced risk associated with dietary folate intake during pregnancy was only seen for severe preeclampsia (OR=0.52, 95% CI: 0.31-0.87, for the highest quartile of dietary folate intake compared with the lowest). CONCLUSIONS: Our study results suggest that folic acid supplementation and higher dietary folate intake during pregnancy reduce the risk of preeclampsia. Future studies are needed to confirm the associations.
BACKGROUND/ OBJECTIVES:Folic acid supplementation has been suggested to reduce the risk of preeclampsia. However, results from few epidemiologic studies have been inconclusive. We investigated the hypothesis that folic acid supplementation and dietary folate intake before conception and during pregnancy reduce the risk of preeclampsia. SUBJECTS/ METHODS: A birth cohort study was conducted in 2010-2012 at the Gansu Provincial Maternity & Child Care Hospital in Lanzhou, China. A total of 10,041 pregnant women without chronic hypertension or gestational hypertension were enrolled. RESULTS: Compared with nonusers, folic acid supplement users had a reduced risk of preeclampsia (OR=0.61, 95% CI: 0.43-0.87). A significant dose-response of duration of use was observed among women who used folic acid supplemention during pregnancy only (P-trend=0.007). The reduced risk associated with folic acid supplement was similar for mild or severe preeclampsia and for early- or late-onset preeclampsia, although the statistical significant associations were only observed for mild (OR=0.50, 95% CI: 0.30-0.81) and late-onset (OR=0.60, 95% CI: 0.42-0.86) preeclampsia. The reduced risk associated with dietary folate intake during pregnancy was only seen for severe preeclampsia (OR=0.52, 95% CI: 0.31-0.87, for the highest quartile of dietary folate intake compared with the lowest). CONCLUSIONS: Our study results suggest that folic acid supplementation and higher dietary folate intake during pregnancy reduce the risk of preeclampsia. Future studies are needed to confirm the associations.
Authors: S E Vollset; H Refsum; L M Irgens; B M Emblem; A Tverdal; H K Gjessing; A L Monsen; P M Ueland Journal: Am J Clin Nutr Date: 2000-04 Impact factor: 7.045
Authors: Stuart J Moat; Derek Lang; Ian F W McDowell; Zoe L Clarke; Anil K Madhavan; Malcolm J Lewis; Jonathan Goodfellow Journal: J Nutr Biochem Date: 2004-02 Impact factor: 6.048
Authors: Linda Dodds; Deshayne B Fell; Kent C Dooley; B Anthony Armson; Alexander C Allen; Bassam A Nassar; Sherry Perkins; K S Joseph Journal: Clin Chem Date: 2007-12-10 Impact factor: 8.327
Authors: Janet M Catov; Ellen A Nohr; Lisa M Bodnar; Vibeke K Knudson; Sjurdur F Olsen; Jorn Olsen Journal: Am J Epidemiol Date: 2009-04-16 Impact factor: 4.897